Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MyCelx Technologies Corporation Director's Dealing 2022

May 3, 2022

10837_pos_2022-05-03_7ddf08cb-c591-4fac-b548-f86f9d8e138d.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 9828J

MyCelx Technologies Corporation

03 May 2022

2 May 2022

MYCELX Technologies Corporation

("MYCELX" or the "Company" (AIM: MYX)

Dealing by Director

The Company announces that it was notified on 2 May 2022 by Hal Alper, President, Chief Science Officer and a Director of the Company, that on 10 November 2021 he sold 22,500 Common Shares at a price of £0.70 per Common Share. Following this transaction, he continues to be interested in 1,219,546 Common Shares representing 5.31 per cent of the present issued capital of the Company and in 124,339 options over the Company's Common Shares.

For further information please contact:

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO
Tel: +1 888 306 6843
Canaccord Genuity, Nominated Adviser

Henry Fitzgerald-O'Connor

Gordon Hamilton
Tel: + 44 20 7523 8000
Celicourt

Mark Antelme

Jimmy Lea
Tel: +44 20 8434 2754

Notification of transactions of persons discharging managerial responsibility or connected persons

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Hal Alper

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MYCELX Technologies Corporation

b)

LEI

213800UJZINIK2VD1G48

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Common shares of US$0.025

USU624551078

b)

Nature of the transaction

Disposal of Common Shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
£0.70 22,500

d)

Aggregated information

- Aggregated volume

- Price

n/a

n/a

e)

Date of the transaction

10/11/2021

f)

Place of the transaction

London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFFFEIELIFIIF